Epigenetic modifications in hepatocellular carcinoma: A literature review
Rawal Medical Journal · 2025 · 50 (2) · 514
DOI: 10.5455/rmj.20240425033740 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rawal Medical Journal, 2025. Verfasst von Taufik Sungkar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Understanding the epigenetic mechanisms has opened new avenues for the potential reversibility of epigenetic alterations and provided an opportunity to influence and control their unfavorable consequences. These findings not only aid in identifying novel targets for therapy but also enable the prediction of treatment response. Investigating epigenetics can uncover new targets for more effective therapeutic strategies and identify novel biomarkers for diagnosing HCC in the future.
Zitieren
APA
Sungkar, T., Darmadi, D., Pakpahan, C., & Lubis, A. (2025). Epigenetic modifications in hepatocellular carcinoma: A literature review. Rawal Medical Journal, 50(2), 514. https://doi.org/10.5455/rmj.20240425033740
Vancouver
Sungkar T, Darmadi D, Pakpahan C, Lubis A. Epigenetic modifications in hepatocellular carcinoma: A literature review. Rawal Medical Journal. 2025;50(2):514. doi:10.5455/rmj.20240425033740
BibTeX
@article{Sungkar2025,
author = {Sungkar, Taufik and Darmadi, Darmadi and Pakpahan, Cennikon and Lubis, Adriansyah},
title = {Epigenetic modifications in hepatocellular carcinoma: A literature review},
journal = {Rawal Medical Journal},
year = {2025},
volume = {50},
number = {2},
pages = {514},
doi = {10.5455/rmj.20240425033740}
}
EUVIMED